Savara Inc (SVRA) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $1.2 billion, Savara Inc is a small-cap company. The stock currently trades at $5.76, down 4.16% today, with a 52-week range of $1.89–$7.00.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.48 | $-0.48 | -45.5% | |
| 2023 | $-0.33 | $-0.33 | -32.0% | |
| 2022 | $-0.25 | $-0.25 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — | |
| 2014 | — | — | — | |
| 2013 | — | — | — | |
| 2012 | — | — | — | |
| 2011 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-27 | 0000950170-25-045731 | SEC ↗ |
| 2023-12-31 | 2024-03-07 | 0000950170-24-027920 | SEC ↗ |
| 2022-12-31 | 2023-03-30 | 0000950170-23-010967 | SEC ↗ |
| 2021-12-31 | 2022-03-30 | 0000950170-22-005045 | SEC ↗ |
| 2020-12-31 | 2021-03-10 | 0001564590-21-011919 | SEC ↗ |
| 2019-12-31 | 2020-03-12 | 0001564590-20-010465 | SEC ↗ |
| 2018-12-31 | 2019-03-13 | 0001564590-19-007585 | SEC ↗ |
| 2017-12-31 | 2018-03-14 | 0001564590-18-005610 | SEC ↗ |
| 2016-12-31 | 2017-03-06 | 0001564590-17-003487 | SEC ↗ |
| 2015-12-31 | 2016-03-14 | 0001564590-16-014658 | SEC ↗ |
| 2014-12-31 | 2015-03-24 | 0001564590-15-001934 | SEC ↗ |
| 2013-12-31 | 2014-03-26 | 0001193125-14-115663 | SEC ↗ |
| 2012-12-31 | 2013-03-19 | 0001193125-13-115333 | SEC ↗ |
| 2011-12-31 | 2012-03-08 | 0001193125-12-103745 | SEC ↗ |
| 2010-12-31 | 2011-03-10 | 0000950123-11-024172 | SEC ↗ |
| 2009-12-31 | 2010-03-18 | 0000950123-10-026059 | SEC ↗ |